CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 77 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,573 | -13.1% | 10,217 | -23.7% | 0.00% | – |
| Q1 2023 | $20,229 | -87.8% | 13,397 | -87.1% | 0.00% | – |
| Q4 2022 | $166,279 | -14.3% | 103,924 | -22.3% | 0.00% | – |
| Q3 2022 | $194,000 | -43.4% | 133,693 | -28.7% | 0.00% | – |
| Q2 2022 | $343,000 | -83.1% | 187,542 | -75.3% | 0.00% | – |
| Q1 2022 | $2,026,000 | -26.5% | 758,589 | +19.1% | 0.00% | -100.0% |
| Q4 2021 | $2,758,000 | -51.1% | 636,946 | -42.6% | 0.00% | 0.0% |
| Q3 2021 | $5,645,000 | -6.3% | 1,109,065 | +16.5% | 0.00% | 0.0% |
| Q2 2021 | $6,026,000 | +272.9% | 952,017 | +355.3% | 0.00% | – |
| Q1 2021 | $1,616,000 | +8.5% | 209,102 | -8.1% | 0.00% | – |
| Q4 2020 | $1,490,000 | -19.9% | 227,449 | -18.7% | 0.00% | -100.0% |
| Q3 2020 | $1,861,000 | -19.6% | 279,823 | +0.7% | 0.00% | 0.0% |
| Q2 2020 | $2,315,000 | +118.6% | 277,845 | +101.3% | 0.00% | – |
| Q1 2020 | $1,059,000 | -68.2% | 138,048 | -65.5% | 0.00% | -100.0% |
| Q4 2019 | $3,328,000 | +16.0% | 400,455 | +3.0% | 0.00% | 0.0% |
| Q3 2019 | $2,869,000 | -37.1% | 388,730 | -4.3% | 0.00% | 0.0% |
| Q2 2019 | $4,559,000 | +114.8% | 406,357 | +105.9% | 0.00% | 0.0% |
| Q1 2019 | $2,122,000 | -71.8% | 197,375 | -60.4% | 0.00% | -50.0% |
| Q4 2018 | $7,521,000 | -10.9% | 498,092 | +9.2% | 0.00% | 0.0% |
| Q3 2018 | $8,437,000 | -29.2% | 456,053 | -12.5% | 0.00% | -33.3% |
| Q2 2018 | $11,913,000 | -0.0% | 521,108 | +24.4% | 0.00% | 0.0% |
| Q1 2018 | $11,917,000 | +23.4% | 418,892 | -8.5% | 0.00% | +50.0% |
| Q4 2017 | $9,660,000 | +63.5% | 457,619 | +40.7% | 0.00% | +100.0% |
| Q3 2017 | $5,909,000 | +198.4% | 325,165 | +154.5% | 0.00% | 0.0% |
| Q2 2017 | $1,980,000 | +942.1% | 127,776 | +1063.5% | 0.00% | – |
| Q1 2017 | $190,000 | -40.4% | 10,982 | -28.1% | 0.00% | – |
| Q4 2015 | $319,000 | – | 15,278 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |